These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 23177651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pediatric FDG PET/CT: physiologic uptake, normal variants, and benign conditions.
    Shammas A, Lim R, Charron M.
    Radiographics; 2009; 29(5):1467-86. PubMed ID: 19755606
    [Abstract] [Full Text] [Related]

  • 4. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U, Even-Sapir E.
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
    Shao D, Tian XW, Gao Q, Liang CH, Wang SX.
    Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
    [Abstract] [Full Text] [Related]

  • 7. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation.
    Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, Kolodny G, Laham R.
    J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C, Bissoli S, Pasquali C, Frison L, Liessi G, Chierichetti F, Pedrazzoli S.
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [Abstract] [Full Text] [Related]

  • 10. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M, Wu N, Liu Y, Zheng R, Liang Y, Zhang W, Zhao P.
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [Abstract] [Full Text] [Related]

  • 11. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
    Yamagishi H, Shirai N, Takagi M, Yoshiyama M, Akioka K, Takeuchi K, Yoshikawa J.
    J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
    [Abstract] [Full Text] [Related]

  • 12. Pitfalls and Misinterpretations of Cardiac Findings on PET/CT Imaging: A Careful Look at the Heart in Oncology Patients.
    Betancourt Cuellar SL, Palacio D, Benveniste MF, Carter BW, Gladish G.
    Curr Probl Diagn Radiol; 2019 Jul; 48(2):172-183. PubMed ID: 29549978
    [Abstract] [Full Text] [Related]

  • 13. Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography.
    Wehrli NE, Bural G, Houseni M, Alkhawaldeh K, Alavi A, Torigian DA.
    Semin Nucl Med; 2007 May; 37(3):195-205. PubMed ID: 17418152
    [Abstract] [Full Text] [Related]

  • 14. Positron emission tomography/computed tomography potential pitfalls and artifacts.
    Wang X, Koch S.
    Curr Probl Diagn Radiol; 2009 May; 38(4):156-69. PubMed ID: 19464586
    [Abstract] [Full Text] [Related]

  • 15. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
    Roivainen A, Parkkola R, Yli-Kerttula T, Lehikoinen P, Viljanen T, Möttönen T, Nuutila P, Minn H.
    Arthritis Rheum; 2003 Nov; 48(11):3077-84. PubMed ID: 14613269
    [Abstract] [Full Text] [Related]

  • 16. Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET.
    Yeung HW, Grewal RK, Gonen M, Schöder H, Larson SM.
    J Nucl Med; 2003 Nov; 44(11):1789-96. PubMed ID: 14602861
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y, Grant C, Xie K, Sweiss NJ.
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of quantitative assessment of cardiac 18F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.
    Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A.
    Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.